Participation in clinical research: Perspectives of adult patients and parents of pediatric patients undergoing hematopoietic stem cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 10, 2014, Pages 1604-1611

  Keusch, Florian ^a   Rao, Rohini ^a,b   Chang, Lawrence ^a,b   Lepkowski, James ^a   Reddy, Pavan ^a,b   Choi, Sung Won ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Bone marrow transplantation; Clinical trials; Focus groups; Hematopoietic stem cell transplantation; Patient research participation; Qualitative research study

Indexed keywords

ADULT; AGED; ALTRUISM; ARTICLE; CLINICAL ARTICLE; CLINICAL RESEARCH; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFORMED CONSENT; MALE; MEDICAL DECISION MAKING; METHODOLOGY; PARENTAL ATTITUDE; PATIENT ATTITUDE; RESEARCH SUBJECT; ADOLESCENT; ALLOTRANSPLANTATION; ATTITUDE TO HEALTH; CLINICAL TRIAL (TOPIC); HEMATOLOGIC DISEASES; INFORMATION PROCESSING; MIDDLE AGED; PATIENT PARTICIPATION; PSYCHOLOGY;

ADOLESCENT; ADULT; AGED; CLINICAL TRIALS AS TOPIC; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFORMED CONSENT; MALE; MIDDLE AGED; PATIENT PARTICIPATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84912529225     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.06.020     Document Type: Article

References (33)

1. Copelan E.A. Hematopoietic stem-cell transplantation. NEngl J Med 2006, 354:1813-1826.
2. Gratwohl A., Baldomero H., Aljurf M., et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010, 303:1617-1624.
3. Pasquini M.C., Wang Z., Horowitz M.M., Gale R.P. 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. Clin Transpl 2010, 87-105.
4. Gooley T.A., Chien J.W., Pergam S.A., et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. NEngl J Med 2010, 363:2091-2101.
5. Ferrara J.L., Anasetti C., Stadtmauer E., et al. Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007. Biol Blood Marrow Transplant 2007, 13:1268-1285.
6. Ferrara J.L. Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007. Biol Blood Marrow Transplant 2014, 20:149-153.
7. Collins FS. The Importance of Clinical Trials. Available at: Last accessed: April 18,2014. http://www.nlm.nih.gov/medlineplus/magazine/issues/summer11/articles/summer11pg2-3.html.
8. Kelley, W.N. (Chairman). Careers in Clinical Research: Obstacles and Opportunities. Committee on Addressing Career Paths for Clinical Research, Institute of Medicine. Washington, D.C.: National Academy Press,1994.
9. Sung N.S., Crowley W.F., Genel M., et al. CEntral challenges facing the national clinical research enterprise. JAMA 2003, 289:1278-1287.
10. Umutyan A., Chiechi C., Beckett L.A., et al. Overcoming barriers to cancer clinical trial accrual: impact of a mass media campaign. Cancer 2008, 112:212-219.
11. das Nair R., Orr K.S., Vedhara K., Kendrick D. Exploring recruitment barriers and facilitators in early cancer detection trials: the use of pre-trial focus groups. Trials 2014, 15:98.
12. Fayter D., McDaid C., Eastwood A. Asystematic review highlights threats to validity in studies of barriers to cancer trial participation. JClin Epidemiol 2007, 60:990-1001.
13. Committee to Review the Clinical and Translational Science Awards Program at the National Center for Advancing Translational Sciences; Board on Health Sciences Policy; Institute of Medicine; The CTSA Program at NIH: Opportunities for Advancing Clinical and Translational Research 2013, National Academies Press (US), Washington (DC). A.I. Leshner, S.F. Terry, A.M. Schultz, C.T. Liverman (Eds.).
14. Selby J.V., Beal A.C., Frank L. The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. JAMA 2012, 307:1583-1584.
15. Miller W.L., Crabtree B.F. Primary care research: A multimethod typology & qualitative roadmap. Doing qualitative research in primary care: Multiple strategies 1992, 3-28. Sage Publications, Newbury Park, CA. B.F. Crabtree, W.L. Miller (Eds.).
16. Hietanen P., Aro A.R., Holli K., Absetz P. Information and communication in the context of a clinical trial. Eur J Cancer 2000, 36:2096-2104.
17. Raich P.C., Kennedy R.L., Vanoni C., et al. Improved understanding and satisfaction with a modified informed consent document: a randomized study. Patient Intelligence 2012, 4:23-39.
18. Denzen E.M., Santibanez M.E., Moore H., et al. Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trials. Biol Blood Marrow Transplant 2012, 18:183-189.
19. Kirsch I., Jungeblut A., Jenkins L., Kolstad A. Adult literacy in America: A first look at the results of the National Adult Literacy Survey 1993, National Center for Education Statistics, US Dept. of Education, Washington, DC.
20. Ellis P.M. Attitudes towards and participation in randomised clinical trialsin oncology: a review of the literature. Ann Oncol 2000, 11:939-945.
21. McPherson C.J., Higginson I.J., Hearn J. Effective methods of giving information in cancer: a systematic literature review of randomized controlled trials. JPublic Health Med 2001, 23:227-234.
22. Woolfall K., Shilling V., Hickey H., et al. Parents' agendas in paediatric clinical trial recruitment are different from researchers' and often remain unvoiced: a qualitative study. PloS oOne 2013, 8:e67352.
23. Davis T.C., Williams M.V., Marin E., et al. Health literacy and cancer communication. CA Cancer J Clin 2002, 52:134-149.
24. Comprehensive Working Group on Informed Consent in Cancer Clinical Trials for the National Cancer Institute: Recommendations for the Development of Informed Consent Documents for Cancer Clinical Trials. NCI, NIH Publication No. 98-4355, 1998. Available at: Last accessed: May 2,2014. http://www.cancer.gov/clinicaltrials/understanding/simplification-of-informed-consent-docs.
25. American Society of Clinical Oncology American Society of Clinical Oncology policy statement: oversight of clinical research. JClin Oncol 2003, 21:2377-2386.
26. Oberman M., Frader J. Dying children and medical research: access to clinical trials as benefit and burden. Am J Law Med 2003, 29:301-317.
27. Jenkins V., Farewell V., Farewell D., et al. Drivers and barriers to patient participation in RCTs. Br J Cancer 2013, 108:1402-1407.
28. Ellis P.M., Butow P.N., Tattersall M.H., et al. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. JClin Oncol 2001, 19:3554-3561.
29. Comis R.L., Miller J.D., Aldige C.R., et al. Public attitudes toward participation in cancer clinical trials. JClin Oncol 2003, 21:830-835.
30. Edwards S.J., Lilford R.J., Thornton J., Hewison J. Informed consent for clinical trials: in search of the "best" method. Soc Sci Med 1998, 47:1825-1840.
31. Hayman R.M., Taylor B.J., Peart N.S., et al. Participation in research: informed consent, motivation and influence. J Paediatr Child Health 2001, 37:51-54.
32. Aaronson N.K., Visser-Pol E., Leenhouts G.H., et al. Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. J Clin Oncol 1996, 14:984-996.
33. Buss M.K., DuBenske L.L., Dinauer S., et al. Patient/Caregiver influences for declining participation in supportive oncology trials. J Support Oncol 2008, 6:168-174.